Other

Repayments of Short-Term Debt

Pfizer Repayments of Short-Term Debt decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $2.05B to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryLeverage
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026

How to read this metric

Higher repayments reduce short-term leverage and interest burden, signaling improved financial health and liquidity management.

Detailed definition

Cash outflows used to settle debt obligations with maturities of one year or less. This reflects the company's ability t...

Peer comparison

Standard line item in the financing section of the cash flow statement for most public companies.

Metric ID: other_repayments_of_short_term_debt

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q1 '26
Value$0.00$1.00M-$1.00M$971.75M$971.75M$971.75M$971.75M$0.00$0.00$0.00$3.00M$328.00M$4.52B$2.92B$3.45B$2.05B$151.00M$0.00
QoQ Change-200.0%>999%+0.0%+0.0%+0.0%-100.0%>999%>999%-35.4%+18.1%-40.7%-92.6%-100.0%
YoY Change>999%>999%-100.0%-100.0%-100.0%-99.7%>999%+524.4%-96.7%-100.0%
Range-$1.00M$4.52B
Avg YoY Growth>999%
Median YoY Growth-98.2%
Current Streak3 quarters decline

Frequently Asked Questions

What is Pfizer's repayments of short-term debt?
Pfizer (PFE) reported repayments of short-term debt of $0.00 in Q1 2026.
How has Pfizer's repayments of short-term debt changed year-over-year?
Pfizer's repayments of short-term debt decreased by 100.0% year-over-year, from $2.05B to $0.00.
What does repayments of short-term debt mean?
Cash used to pay off short-term loans.